The DOI matches its Crossref record; 57 of the 59 references it cites were found in a registry or an index; none of the 22 sources its claims cite is checked for support yet.
Two genetic variants of CD38 in subjects with autism spectrum disorder and controls
Open accessAbstract
The neurobiological basis of autism spectrum disorder (ASD) remains poorly understood. Given the role of CD38 in social recognition through oxytocin (OT) release, we hypothesized that CD38 may play a role in the etiology of ASD. Here, we first examined the immunohistochemical expression of CD38 in the hypothalamus of post-mortem brains of non-ASD subjects and found that CD38 was colocalized with OT in secretory neurons. In studies of the association between CD38 and autism, we analyzed 10 single nucleotide polymorphisms (SNPs) and mutations of CD38 by re-sequencing DNAs mainly from a case-control study in Japan, and Caucasian cases mainly recruited to the Autism Genetic Resource Exchange (AGRE). The SNPs of CD38, rs6449197 (p<0.040) and rs3796863 (p<0.005) showed significant associations with a subset of ASD (IQ>70; designated as high-functioning autism (HFA)) in the U.S. 104 AGRE family trios, but not with Japanese 188 HFA subjects. A mutation that caused tryptophan to replace arginine at amino acid residue 140 (R140W; (rs1800561, 4693C>T)) was found in 0.6-4.6% of the Japanese population and was associated with ASD in the smaller case-control study. The SNP was clustered in pedigrees in which the fathers and brothers of T-allele-carrier probands had ASD or ASD traits. In this cohort OT plasma levels were lower in subjects with the T allele than in those without. One proband with the T allele who was taking nasal OT spray showed relief of symptoms. The two variant CD38 poloymorphysms tested may be of interest with regard of the pathophysiology of ASD.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This study examined CD38 variants in autism spectrum disorder (ASD), finding that CD38 colocalizes with oxytocin in human hypothalamic neurons and that two CD38 polymorphisms were associated with high-functioning autism in U.S. AGRE trios but not Japanese HFA trios. A rare R140W mutation was linked to lower plasma oxytocin in a small subset and one carrier reportedly improved on intranasal oxytocin.
Key findings
- CD38 immunoreactivity colocalized extensively with oxytocin in the paraventricular nucleus of the human hypothalamus; highest CD38 expression was in hypothalamus, with substantial expression in frontal cortex, amygdala, and cerebellum.
- In U.S. AGRE HFA trios (IQ>70; 104 trios), rs6449197 (p=0.040) and rs3796863 (p=0.005) were significantly associated with ASD; rs3796863 showed only a tendency in all 252 AGRE trios (p=0.088), and no association was detected in 188 Japanese HFA trios (p=0.228). The second haplotype block (SNPs06–07) showed strong association in HFA trios (p=0.001), with the CT haplotype significant after permutation (p=0.005; overtransmitted 69.18%).
- The R140W mutation (rs1800561, 4693C>T) was found in 0.6%–4.6% of the Japanese population; in cohort 2, 13/301 ASD subjects were heterozygous (allelic frequency 0.022) versus 17/417 controls heterozygous plus one homozygous (allelic frequency 0.023), and the association was not replicated (χ2=1.20, p<0.3). In three families, 18 R140W carriers were identified, 8 of whom had ASD or ASD traits (44%), and no ASD subjects were found without the mutant SNP.
- Plasma oxytocin was lower in ASD probands with the W140 allele (79.3 ± 14.9 pg/ml; n=3) than in ASD subjects without it (147.7 ± 15.0 pg/ml; p<0.01; n=26) and controls with R140 (198.2 ± 24.7 pg/ml; p<0.01; n=100); AVP was slightly higher in W140 probands (38.9 ± 3.8 vs 26.9 ± 5.0 pg/ml; p<0.05). One 23-year-old proband with the W140 allele received nasal oxytocin and showed maintained improvement for more than 20 months.
Methods
- Immunohistochemistry and RT-PCR were used on post-mortem human brain tissue to assess CD38 expression and colocalization with oxytocin, including hypothalamic paraventricular nucleus and insular cortex as control.
- Genetic analyses included 10 intronic SNPs and exonic mutation screening of CD38 across Japanese case-control cohorts (29 ASD/315 controls; 301 ASD/417 controls), 188 Japanese HFA trios, 16 Korean ASD/150 controls, 252 AGRE trios including 104 U.S. HFA trios, plus Russian and Italian samples; analyses used FBAT, TDT, haplotype tests, ANOVA, and permutation.
- Plasma oxytocin and vasopressin were measured by enzyme immunoassay; ASD traits in relatives were assessed with the Autism-Spectrum Quotient (AQ), and one proband received intranasal oxytocin.
Limitations
- The paper states “despite their statistical limitations” and calls for functional and expression assays to assess biological effects of the variants, as well as further systematic case-control investigations to verify oxytocin treatment effects.
- The association findings did not replicate in Japanese HFA trios or in the larger Japanese R140W case-control cohort, and the functional importance of the intronic rs3796863 SNP “remains to be determined.”
- Evident from the text: plasma oxytocin comparisons for W140 carriers relied on very small numbers (n=3 ASD probands; only one control W140 carrier), the intranasal oxytocin report is a single uncontrolled proband, and the structural analysis is described as preliminary.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
50 Own result · 12 Not checked yet · 9 Own interpretation · 7 Own method · 1 No basis given
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“An association study for 10 intronic SNPs shown in Fig. 2 was first performed in a case-control study in a Japanese population (29 ASD subjects and 315 controls, the first cohort in the Table 1).No significant association with ASD was found for these SNPs (data not shown).”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 3.1. Intronic SNP analysis in Japanese and U.S. subjects
plainn = 29- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Unlike the U.S. cases, no association was detected in 188 Japanese HFA trio cases selected from cohort 2 (p=0.228).”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 3.1. Intronic SNP analysis in Japanese and U.S. subjects
plainn = 188- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Linkage disequilibrium (LD) analysis identified three haplotype blocks across the CD38 gene in 104 trios in AGRE samples, with the first block comprising SNPs01-05, the second block comprising SNPs06 and 07, and the third block comprising SNPs08 and 09 (Fig. 4).”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 3.1. Intronic SNP analysis in Japanese and U.S. subjects
plainn = 104- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the FBAT of HFA trios, rs6449197 (p=0.040) and rs3796863 (p=0.005)showed significant associations”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 3.1. Intronic SNP analysis in Japanese and U.S. subjects
plaincorrelationaln = 104 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the FBAT of HFA trios, rs6449197 (p=0.040) and rs3796863 (p=0.005)showed significant associations”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 3.1. Intronic SNP analysis in Japanese and U.S. subjects
plaincorrelationaln = 104 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Again, none of the SNPs showed significant associations, except rs3796863 (SNP06) with a tendency toward association (p=0.088;Table 4).”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 3.1. Intronic SNP analysis in Japanese and U.S. subjects
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Following post hoc pairwise comparison with the Bonferroni method, the variations in the distribution of ADI-R_C between the C/C and C/A groups were found to be significant at the 0.05-and 0.01-levels, in the 252 and HFA trios, respectively.”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 3.1. Intronic SNP analysis in Japanese and U.S. subjects
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“CD38 immunoreactivity was detected in the hypothalamus of the two Japanese brains (data not shown).”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 3. Results
plainn = 2- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we first examined the immunohistochemical expression of CD38 in the hypothalamus of post-mortem brains of non-ASD subjects and found that CD38 was colocalized with OT in secretory neurons.”
- Also stated in: § 3. Results · plain
“double immunohistochemical staining revealed high levels of CD38 immunoreactivity in many cells in the paraventricular nucleus of the hypothalamus and showed extensive colabeling with OT”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > Abstract
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 3. Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A weak association was detected for rs1800561 (R140W) in adult ASD patients”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 3.2. Mutation analysis
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 21
- The quote only partly states this claim. 1
- Probably not a substantial claim. 14
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The highest level of CD38 expression was detected in the human hypothalamus, and we detected substantial expression in the frontal cortex, amygdala, and cerebellum (data not shown).”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 3. Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“One-way ANOVA showed a significant variation in the distribution of ADI-R_C scores (restricted, repetitive, and stereotyped patterns of behavior) between the C/C, C/A, and A/A genotypes of SNP06 of CD38, in 252 trios (p=0.013) and HFA trios (p=0.0067) (Fig. 3).”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 3.1. Intronic SNP analysis in Japanese and U.S. subjects
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The haplotypes GGCAG (p=0.022) and GGTAG (p=0.034) of this block showed significant associations; however, this was not significant by permutation (permutation p=0.157 for GGCAG and permutation p=0.271 for GGTAG).”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 3.1. Intronic SNP analysis in Japanese and U.S. subjects
plaincorrelationaln = 104 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In this block, the haplotypes AT (p=0.015) and CT (p=0.0007)showed significant associations; the association shown by CT remained significant (permutation p=0.005), while that of AT was not significant (permutation p=0.12), by permutation.”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 3.1. Intronic SNP analysis in Japanese and U.S. subjects
plaincorrelationaln = 104- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Furthermore, although we detected the SNP in 5 of the 150 Korean controls, it was not detected it among the 16 Korean patients (cohort 3 in Table 1) or the 263 Caucasian patients (cohort 4 in Table 1).”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 3.2. Mutation analysis
plainn = 16- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The haplotypes of the 3 rd haploblock, which included SNPs 08 and 09, did not show any association with HFA.None of the haplotypes in the 252 trios showed significant association.”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 3.1. Intronic SNP analysis in Japanese and U.S. subjects
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The immediate effect of OT was obvious after the first trial, in which he was no longer boisterous after awaking early in the morning.This quieting on awaking has been maintained for more than 20 months.He showed improvements in eye contact behavior with smiling and answering to yes/no questions in his daily life.There were no significant adverse effects.”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 3.4. Plasma OT and vasopressin levels
plaindirectSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one. The quote only partly states this claim.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mutant structure is more open and has a slightly larger degree of variation (Fig. 7C and E).”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 4. Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mutant structure has a more the open conformation than the wild-type and a slightly larger degree of variation.”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 4. Discussion
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: The predicted protein structures and molecular dynamics simulations accurately reflect the actual structural and dynamic properties of W140-CD38.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The W140 protein has an outward conformation and fewer interacting residues than the wild-type protein.”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 4. Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: The predicted protein structures and molecular dynamics simulations accurately reflect the actual structural and dynamic properties of W140-CD38.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Amino acid sequence of CD38 showing conservation of R at the 140th amino acid among different species, except for rodents and rabbits.”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 4. Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“R140 and W140 are packed into the helix, and the packing conformation seems stable.”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 4. Discussion
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: The predicted protein structures and molecular dynamics simulations accurately reflect the actual structural and dynamic properties of W140-CD38.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, taking into account the results that the W140 allele is not associated with ASD in general population, we can only say that the W140 allele is deemed to have a role in decreased plasma OT levels, but not in AVP levels, regardless of disease status.”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 4. Discussion
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Based on the results of SNP-and haplotype-TDT analyses, the A allele of rs3796863 of CD38 may be considered a protective allele and the C allele as a risk allele for U.S. HFA cases.”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 4. Discussion
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Oxytocin (OT) is secreted into the brain by hypothalamic neuronal dendrites and plays important roles in social recognition and memory (Insel & Fernald, 2004;Takayanagi et al., 2005;Donaldson et al., 2008;Neumann, 2008).”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 1. Introduction
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Peripheral or nasal administration of OT facilitates social recognition and trust in healthy humans (Guastella et al., 2008a andb, 2009;Ditzen et al., 2009) and increases eye contact and recognition in autistic subjects (Hollander et al., 2007;Yamasue et al., 2009).”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 1. Introduction
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The use of this tissue followed the institutional guidelines established by the Committee on Human Research (CHR) in both universities.”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 2.1. CD38 expression and immunohistochemistry
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The diagnoses were made by two experienced child psychiatrists through interviews and clinical record reviews, and the subjects had no apparent physical anomalies.”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 2.1. CD38 expression and immunohistochemistry
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“The CD38 gene consists of 8 exons on 4p15 (Nakagawa et al., 1995) and spans a genomic stretch of 70.51 kb.”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 1. Introduction
What the sources say
- Not checked yetcites Nakagawa et al., 1995
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Additional selection criteria required that (i) there be no possible non-idiopathic autism flags and (ii) all the trios be Whites, with the exclusion of Hispanic and Latino races (Anita et al., 2008).”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 2.1. CD38 expression and immunohistochemistry
What the sources say
- Not checked yetcites Anita et al., 2008
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“In the Japanese cohorts, all subjects resided in Kanazawa, Hamamatsu/Nagoya, Tokyo, or Osaka, Japan, and all patients and controls were Japanese with no non-Japanese parents or grandparents.”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 2.1. CD38 expression and immunohistochemistry
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Human CD38 is a type II transmembrane antigen (Malavasi et al., 2008).”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 1. Introduction
What the sources say
- Not checked yetcites Malavasi et al., 2008 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“CD38 is expressed in the brain (Lee, 2001;Higashida et al., 2007) and can catalyze the formation of cyclic ADP-ribose (cADPR) from NAD + (Lee, 2001;Guse, 2005;Malvasi et al., 2008).”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 1. Introduction
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“This study was approved by the ethics committees of Kanazawa University, Hamamatsu Medical University, University of Tokyo, Osaka University, RIKEN, and the other participating institutes.”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 2.1. CD38 expression and immunohistochemistry
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Two experienced child psychiatrists independently confirmed the diagnosis of ASD for most patients by semi-structured behavior observation and interviews with the subjects and their parents.”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 2.1. CD38 expression and immunohistochemistry
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“PedCheck program v1.1 (http://watson.hgen.pitt.edu)was used to identify and eliminate all Mendelian inheritance inconsistencies in the trio genotype data.”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 2.6. Statistics
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“cADPR mobilizes Ca 2+ from intracellular Ca 2+ stores, thus acting as a second messenger (Lee, 2001).”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 1. Introduction
What the sources say
- Not checked yetcites Lee, 2001 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“They showed that CD38 regulates OT secretion in the mouse hypothalamus and posterior pituitary, which is critical for mouse social behavior (Jin et al., 2007;Liu et al., 2008).”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 1. Introduction
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In conclusion, despite their statistical limitations, our results suggest that the rs3796863 SNP may contribute to genetic susceptibility to HFA in U.S. but not necessarily in Japanese subjects (at least to the limits of our current analysis).”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 4. Discussion
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: The association between rs3796863 and HFA in U.S. trios is not due to population stratification or other confounding that would produce a spurious association.
The authors state this as an assumption.
The precise role of CD38 in the human hypothalamus was not clarified before this study.
“The precise role of CD38 in the human hypothalamus, however, has not been clarified.”
The authors state this as an assumption.
The effects of long-term OT treatment on human social behavior in ASD patients were unknown before this study.
“Those observations are based mostly on a small number of administrations, and the effects of long-term OT treatment on human social behavior in ASD patients is unknown.”
The paper relies on this without support.
The unscreened control subjects in cohort 2 were free of ASD.
“In 417 unscreened control subjects without ASD, 10 males and 7 females were heterozygous for the mutation and one female was homozygous (allelic frequency, 0.023).”
The paper relies on this without support.
The association between rs3796863 and HFA in U.S. trios is not due to population stratification or other confounding that would produce a spurious association.
“In conclusion, despite their statistical limitations, our results suggest that the rs3796863 SNP may contribute to genetic susceptibility to HFA in U.S. but not necessarily in Japanese subjects (at least to the limits of our current analysis).”
The paper relies on this without support.
The CHO cell and Cd38 null mouse models used in the cited studies are valid models for human W140-CD38 function.
“In CHO cells, in fact, the W140-CD38 protein possesses only one third of the ADP-ribosyl cyclase activity of R140-CD38 (Yagui et al., 1998).Moreover, social amnesia was not rescued by local re-expression of human W140-CD38 in the hypothalamus in the Cd38 null mice (Jin et al., 2007).”
The paper relies on this without support.
The predicted protein structures and molecular dynamics simulations accurately reflect the actual structural and dynamic properties of W140-CD38.
“The mutant structure has a more the open conformation than the wild-type and a slightly larger degree of variation.”
The paper relies on this without support.
Low blood oxytocin levels in ASD patients reflect central oxytocin function relevant to social behavior.
“Furthermore, the W140 allele could be a potential risk factor for a subset of Japanese ASD patients, i.e., males with low blood OT levels.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The highest level of CD38 was found in the hypothalamus (Munesue et al., 2010).”
From CD38 and its role in oxytocin secretion and social behavior (2012) · cites this paper as Munesue et al., 2010
In the citing paper
“Therefore, the R140W mutation causes significant modifications and damage to the predicted protein structure in comparison with the human wild-type (R140) CD38 (see Fig. 7 of Munesue et al., 2010).”
From CD38 and its role in oxytocin secretion and social behavior (2012) · cites this paper as Munesue et al., 2010
In the citing paper
“Our preliminary studies suggest that a subgroup of ASD subjects with the R140W SNP and intelligence impairments may be effectively treated with OXT (Munesue et al., 2010)”
From CD38 and its role in oxytocin secretion and social behavior (2012) · cites this paper as Munesue et al., 2010
In the citing paper
“The OXT plasma concentrations of the five R140W carriers (79.2 ± 16.6 pg/ml; n = 5; Munesue et al., 2010) were lower than those of ASD subjects lacking the mutation (147.7 ± 15.0 pg/ml; p < 0.01; n = 26).”
From CD38 and its role in oxytocin secretion and social behavior (2012) · cites this paper as Munesue et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 1. Introduction
“We measured the carrier's serum OT levels and examined each subject for ASD.”
§ Two genetic variants of CD38 in subjects with autism spectrum disorder and controls > 2.5. Enzyme immunoassay for OT and vasopressin
“The samples were centrifuged at 0°C at 2,600 x g for 15 min and the plasma was separated off, divided into 2 tubes, and stored at -80°C.We performed the peptide assay for OT and vasopressin (AVP) as described previously (Jin et al., 2007;Liu et al., 2008).”
Citations
Cites
Lord, C., Rutter, M., & Le Couteur, A. (1994) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172145 · Cited by 9,065
Oxytocin increases trust in humans
Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005) · Nature · doi:10.1038/nature03701 · Cited by 3,690
Strong association of de novo copy number mutations with autism
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al. (2007) · Science · doi:10.1126/science.1138659 · Cited by 2,795
Baird, G., Simonoff, E., Pickles, A., Chandler, S., Loucas, T., Meldrum, D., & Charman, T. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69041-7 · Cited by 2,104
Oxytocin, vasopressin, and the neurogenetics of sociality
Donaldson, Z. R., & Young, L. J. (2008) · Science · doi:10.1126/science.1158668 · Cited by 1,645
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes
Glessner, J. T., Wang, K., Cai, G., Korvatska, O., Kim, C. E., Wood, S., Zhang, H., Estes, A., Brune, C. W., Bradfield, J. P., et al. (2009) · Nature · doi:10.1038/nature07953 · Cited by 1,421
Oxytocin improves “mind-reading” in humans
Domes, G., Heinrichs, M., Michel, A., Berger, C., & Herpertz, S. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.015 · Cited by 1,298
Social amnesia in mice lacking the oxytocin gene
Ferguson, J. N., Young, L. J., Hearn, E. F., Matzuk, M. M., Insel, T. R., & Winslow, J. T. (2000) · Nature Genetics · doi:10.1038/77040 · Cited by 1,130
Common genetic variants on 5p14.1 associate with autism spectrum disorders
Wang, K., Zhang, H., Ma, D., Bucan, M., Glessner, J. T., Abrahams, B. S., Salyakina, D., Imielinski, M., Bradfield, J. P., Sleiman, P. M. A., et al. (2009) · Nature · doi:10.1038/nature07999 · Cited by 989
Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.
Guastella, A. J., Einfeld, S. L., Gray, K. M., Rinehart, N. J., Tonge, B. J., Lambert, T. J., & Hickie, I. B. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.020 · Cited by 962
Cited by
Sorted by citations
Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3044 · Cited by 1,688
Oxytocin and social affiliation in humans
Feldman, R. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.01.008 · Cited by 767
Feldman, R., Gordon, I., Influs, M., Gutbir, T., & Ebstein, R. P. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.22 · Cited by 622
Psychological effects of breastfeeding on children and mothers
Krol, K. M., & Grossmann, T. (2018) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-018-2769-0 · Cited by 407
Sensitive Parenting Is Associated with Plasma Oxytocin and Polymorphisms in the OXTR and CD38 Genes
Feldman, R., Zagoory-Sharon, O., Weisman, O., Schneiderman, I., Gordon, I., Maoz, R., Shalev, I., & Ebstein, R. P. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.025 · Cited by 393
Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism
Peñagarikano, O., Lázaro, M. T., Lu, X.-H., Gordon, A., Dong, H., Lam, H. A., Peles, E., Maidment, N. T., Murphy, N. P., Yang, X. W., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010257 · Cited by 378
From cohorts to molecules: adverse impacts of endocrine disrupting mixtures
Caporale, N., Leemans, M., Birgersson, L., Germain, P.-L., Cheroni, C., Borbély, G., Engdahl, E., Lindh, C., Bressan, R. B., Cavallo, F., et al. (2022) · Science · doi:10.1126/science.abe8244 · Cited by 368
Feldman, R., Monakhov, M., Pratt, M., & Ebstein, R. P. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.008 · Cited by 352
The contributions of oxytocin and vasopressin pathway genes to human behavior
Ebstein, R. P., Knafo, A., Mankuta, D., Chew, S. H., & Lai, P. S. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.12.014 · Cited by 283
CD38 and CD157: A long journey from activation markers to multifunctional molecules
Quarona, V., Zaccarello, G., Chillemi, A., Brunetti, E., Singh, V. K., Ferrero, E., Funaro, A., Horenstein, A. L., & Malavasi, F. (2013) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.21092 · Cited by 269
Self-citationQuintana, D. S., Lischke, A., Grace, S., Scheele, D., Ma, Y., & Becker, B. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00864-7 · Cited by 263
Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications
Jiang, C.-C., Lin, L., Long, S., Ke, X., Fukunaga, K., Lu, Y., & Han, F. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01081-0 · Cited by 295
The Emerging Picture of Autism Spectrum Disorder: Genetics and Pathology
Chen, J. A., Peñagarikano, O., Belgard, T. G., Swarup, V., & Geschwind, D. H. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040405 · Cited by 254
CD38 and chronic lymphocytic leukemia: a decade later
Malavasi, F., Deaglio, S., Damle, R. N., Cutrona, G., Ferrarini, M., & Chiorazzi, N. (2011) · Blood · doi:10.1182/blood-2011-06-275610 · Cited by 224
Self-citationSocial attention: a possible early indicator of efficacy in autism clinical trials
Dawson, G., Bernier, R., & Ring, R. H. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-11 · Cited by 193
Shearer, K. D., Stoney, P. N., Morgan, P. J., & McCaffery, P. J. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.08.005 · Cited by 152
Simola, N., & Granon, S. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.008 · Cited by 166
Yamasue, H., Yee, J. R., Hurlemann, R., Rilling, J. K., Chen, F. S., Meyer-Lindenberg, A., & Tost, H. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3327-12.2012 · Cited by 149
Self-citationNeural Circuits for Social Cognition: Implications for Autism
Fernández, M. C., Mollinedo-Gajate, I., & Peñagarikano, O. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.07.013 · Cited by 143
Yang, C.-J., Tan, H.-P., & Du, Y.-J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.02.021 · Cited by 132
Oxytocin in the socioemotional brain: implications for psychiatric disorders
Kirsch, P. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.4/pkirsch · Cited by 123
Liu, J., Liu, X., Xiong, X.-Q., Yang, T., Cui, T., Hou, N.-L., Lai, X., Liu, S., Guo, M., Liang, X.-H., et al. (2017) · BMC Microbiology · doi:10.1186/s12866-017-1096-1 · Cited by 115
Oxytocin and Autism: A Systematic Review of Randomized Controlled Trials
Preti, A., Melis, M., Siddi, S., Vellante, M., Doneddu, G., & Fadda, R. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0040 · Cited by 118
Oxytocin and Autism Spectrum Disorders
Yamasue, H., & Domes, G. (2017) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2017_24 · Cited by 109
Self-citationLerer, E., Levi, S., Israel, S., Yaari, M., Nemanov, L., Mankuta, D., Yirmiya, N., & Ebstein, R. P. (2010) · Autism Research · doi:10.1002/aur.156 · Cited by 106
Oxytocin levels tend to be lower in autistic children: A meta-analysis of 31 studies
John, S., & Jaeggi, A. V. (2021) · Autism · doi:10.1177/13623613211034375 · Cited by 105
Complex epigenetic regulation of Engrailed-2 (EN-2) homeobox gene in the autism cerebellum
James, S. J., Shpyleva, S., Melnyk, S., Pavliv, O., & Pogribny, I. P. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.8 · Cited by 100
Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders
Francis, S. M., Sagar, A., Levin-Decanini, T., Liu, W., Carter, C. S., & Jacob, S. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.021 · Cited by 101
CD38 and its role in oxytocin secretion and social behavior
Higashida, H., Yokoyama, S., Kikuchi, M., & Munesue, T. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.12.011 · Cited by 98
Self-citationHigashida, H., Lopatina, O., Yoshihara, T., Pichugina, Y. A., Soumarokov, A. A., Munesue, T., Minabe, Y., Kikuchi, M., Ono, Y., Korshunova, N., et al. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.01976.x · Cited by 98
Self-citationStavropoulos, K. K. M., & Carver, L. J. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12061 · Cited by 104
Alvares, G. A., Quintana, D. S., & Whitehouse, A. J. O. (2017) · Autism Research · doi:10.1002/aur.1692 · Cited by 91
Sauer, C., Montag, C., Wörner, C., Kirsch, P., & Reuter, M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.333 · Cited by 90
Feldman, R., Vengrober, A., & Ebstein, R. P. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.6 · Cited by 87
Munesue, T., Nakamura, H., Kikuchi, M., Miura, Y., Takeuchi, N., Anme, T., Nanba, E., Adachi, K., Tsubouchi, K., Sai, Y., et al. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00002 · Cited by 84
Self-citationMoskal, J. R., Burgdorf, J. S., Kroes, R. A., Brudzyński, S. M., & Panksepp, J. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.06.006 · Cited by 83
Algoe, S. B., & Way, B. M. (2014) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nst182 · Cited by 79
Oxytocin: a therapeutic target for mental disorders
Matsuzaki, M., Matsushita, H., Tomizawa, K., & Matsui, H. (2012) · The Journal of Physiological Sciences · doi:10.1007/s12576-012-0232-9 · Cited by 79
Husarova, V. M., Lakatošová, S., Pivovarciova, A., Babinská, K., Bakoš, J., Durdiaková, J., Kubranská, A., Ondrejka, I., & Ostatníková, D. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.2.174 · Cited by 82
Examining Autism Spectrum Disorders by Biomarkers: Example From the Oxytocin and Serotonin Systems
Hammock, E. A. D., Veenstra-VanderWeele, J. M., Yan, Z., Kerr, T. M., Morris, M., Anderson, G. M., Carter, C. S., Cook, E. H., & Jacob, S. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.04.010 · Cited by 80
Oxytocin Modulation of Neural Circuits
Mitre, M., Minder, J. L., Morina, E., Chao, M. V., & Froemke, R. C. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_7 · Cited by 79
Zhang, R., Zhang, H.-F., Han, J., & Han, S. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0120-7 · Cited by 84
Tsuji, S., Yuhi, T., Furuhara, K., Ohta, S., Shimizu, Y., & Higashida, H. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00058 · Cited by 75
Self-citationHigashida, H., Yokoyama, S., Huang, J., Liu, L., Ma, W., Akther, S., Higashida, C., Kikuchi, M., Minabe, Y., & Munesue, T. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.01.030 · Cited by 74
Self-citationWaltes, R., Duketis, E., Knapp, M., Anney, R. J. L., Huguet, G., Schlitt, S., Jarczok, T. A., Sachse, M., Kämpfer, L. M., Kleinböck, T., et al. (2014) · Human Genetics · doi:10.1007/s00439-013-1416-y · Cited by 71
Riebold, M., Mankuta, D., Lerer, E., Israel, S., Zhong, S., Nemanov, L., Monakhov, M. V., Levi, S., Yirmiya, N., Yaari, M., et al. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00080 · Cited by 71
Self-citationCD38 in the nucleus accumbens and oxytocin are related to paternal behavior in mice
Akther, S., Korshnova, N., Zhong, J., Liang, M., Михайлович, Ч. С., Lopatina, O., Komleva, Y. K., Salmina, A. B., Nishimura, T., Fakhrul, A. A. K. M., et al. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-41 · Cited by 68
Self-citationLong-term oxytocin administration improves social behaviors in a girl with autistic disorder
Kosaka, H., Munesue, T., Ishitobi, M., Asano, M., Omori, M., Sato, M., Tomoda, A., & Wada, Y. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-110 · Cited by 65
Self-citationThe Roles of Oxytocin and CD38 in Social or Parental Behaviors
Lopatina, O. L., Ивановна, И. А., Salmina, A. B., & Higashida, H. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00182 · Cited by 66
Self-citationCd38 Gene Knockout Juvenile Mice: A Model of Oxytocin Signal Defects in Autism
Higashida, H., Yokoyama, S., Munesue, T., Kikuchi, M., Minabe, Y., & Lopatina, O. L. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1369 · Cited by 63
Self-citationKrol, K. M., Monakhov, M. V., Lai, P. S., Ebstein, R. P., & Großmann, T. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506352112 · Cited by 65
Impaired learning and memory in CD38 null mutant mice
Kim, S., Kim, T., Lee, H., Jang, E.-H., Ryu, H.-H., Kang, M., Rah, S., Yoo, J., Lee, B., Kim, J., et al. (2016) · Molecular Brain · doi:10.1186/s13041-016-0195-5 · Cited by 61
Self-citationThe role of oxytocin and vasopressin in emotional and social behaviors
Bachner‐Melman, R., & Ebstein, R. P. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59602-4.00004-6 · Cited by 65
Fujisawa, T. X., Tanaka, S., Saito, D. N., Kosaka, H., & Tomoda, A. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00295 · Cited by 59
Yamasue, H. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12364 · Cited by 58
Self-citationCD38, CD157, and RAGE as Molecular Determinants for Social Behavior
Higashida, H., Hashii, M., Tanaka, Y., Matsukawa, S., Higuchi, Y., Gabata, R., Tsubomoto, M., Seishima, N., Teramachi, M., Kamijima, T., et al. (2019) · Cells · doi:10.3390/cells9010062 · Cited by 58
Self-citationHigashida, H., Munesue, T., Kosaka, H., Yamasue, H., Yokoyama, S., & Kikuchi, M. (2019) · Diseases · doi:10.3390/diseases7010024 · Cited by 65
Self-citationAttempted suicide and oxytocin-related gene polymorphisms
Parris, M. S., Grunebaum, M. F., Galfalvy, H., Andronikashvili, A., Burke, A. K., Yin, H., Min, E., Huang, Y., & Mann, J. J. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.05.022 · Cited by 58
Genetic mechanisms of parenting
Mileva‐Seitz, V. R., Bakermans‐Kranenburg, M. J., & van IJzendoorn, M. H. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.06.003 · Cited by 58
An immunohistochemical, enzymatic, and behavioral study of CD157/BST-1 as a neuroregulator
Higashida, H., Liang, M., Yoshihara, T., Akther, S., Fakhrul, A. A. K. M., Михайлович, Ч. С., Nam, T., Kim, U., Kasai, S., Nishimura, T., et al. (2017) · BMC Neuroscience · doi:10.1186/s12868-017-0350-7 · Cited by 56
Self-citationHattori, T., Kaji, M., Ishii, H., Jureepon, R., Takarada-Iemata, M., Minh Ta, H., Manh Le, T., Konno, A., Hirai, H., Shiraishi, Y., et al. (2017) · Glia · doi:10.1002/glia.23139 · Cited by 53
Self-citationOxytocin in animal models of autism spectrum disorder
Peñagarikano, O. (2016) · Developmental Neurobiology · doi:10.1002/dneu.22449 · Cited by 56
Oxytocin and excitation/inhibition balance in social recognition
Lopatina, O. L., Komleva, Y. K., Gorina, Y. V., Olovyannikova, R. Y., Труфанова, Л. В., Hashimoto, T., Takahashi, T., Kikuchi, M., Minabe, Y., Higashida, H., et al. (2018) · Neuropeptides · doi:10.1016/j.npep.2018.09.003 · Cited by 53
Self-citationHigashida, H. (2015) · The Journal of Physiological Sciences · doi:10.1007/s12576-015-0425-0 · Cited by 49
Self-citationThanseem, I., Anitha, A., Nakamura, K., Suda, S., Iwata, K., Matsuzaki, H., Ohtsubo, M., Ueki, T., Katayama, T., Iwata, Y., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.020 · Cited by 49
Self-citationSauer, C., Montag, C., Reuter, M., & Kirsch, P. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00045 · Cited by 49
Imaging-Genetics in Autism Spectrum Disorder: Advances, Translational Impact, and Future Directions
Ameis, S. H., & Szatmári, P. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00046 · Cited by 49
Kiss, I., Levy‐Gigi, E., & Kéri, S. (2011) · Biological Psychology · doi:10.1016/j.biopsycho.2011.08.005 · Cited by 45
Lopatina, O. L., Ивановна, И. А., Пичугина, Ю. А., Okamoto, H., Salmina, A. B., & Higashida, H. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02136.x · Cited by 48
Self-citationZhong, J., Amina, S., Liang, M., Akther, S., Yuhi, T., Nishimura, T., Tsuji, C., Tsuji, T., Liu, H.-X., Hashii, M., et al. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00304 · Cited by 42
Self-citationMizuno, A., Михайлович, Ч. С., Kikuchi, Y., Fakhrul, A. A. K. M., Akther, S., Deguchi, K., Yoshihara, T., Ishihara, K., Shuto, S., & Higashida, H. (2015) · Brain Sciences · doi:10.3390/brainsci5010003 · Cited by 43
Self-citationChang, S.-C., Glymour, M. M., Rewak, M., Cornelis, M. C., Walter, S., Koenen, K. C., Kawachi, I. I., Liang, L., Tchetgen, E. J. T., & Kubzansky, L. D. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.09.024 · Cited by 47
Missing and Possible Link between Neuroendocrine Factors, Neuropsychiatric Disorders, and Microglia
Kato, T. A., Hayakawa, K., Monji, A., & Kanba, S. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00053 · Cited by 43
McQuaid, R. J., McInnis, O. A., Matheson, K., & Anisman, H. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00358 · Cited by 42
Common variant in OXTR predicts growth in positive emotions from loving-kindness training
Isgett, S. F., Algoe, S. B., Boulton, A. J., Way, B. M., & Fredrickson, B. L. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.08.010 · Cited by 41
Ma, W.-J., Hashii, M., Munesue, T., Hayashi, K., Yagi, K., Yamagishi, M., Higashida, H., & Yokoyama, S. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-22 · Cited by 46
Self-citationNyffeler, J., Walitza, S., Bobrowski, E., Gundelfinger, R., & Grünblatt, E. (2014) · Journal of Molecular Psychiatry · doi:10.1186/2049-9256-2-1 · Cited by 43
The Role of Intranasal Oxytocin in the Treatment of Patients with Schizophrenia: A Systematic Review
Berardis, D. D., Marini, S., Iasevoli, F., Tomasetti, C., de Bartolomeis, A., Mazza, M., Valchera, A., Fornaro, M., Cavuto, M., Srinivasan, V., et al. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312020012 · Cited by 39
Oxytocin Signaling Pathway: From Cell Biology to Clinical Implications
Iovino, M., Messana, T., Tortora, A., Giusti, C., Lisco, G., Giagulli, V. A., Guastamacchia, E., Pergola, G. D., & Triggiani, V. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200520093730 · Cited by 39
Tabak, B. A., Vrshek‐Schallhorn, S., Zinbarg, R. E., Prenoveau, J. M., Mineka, S., Redei, E. E., Adam, E. K., & Craske, M. G. (2015) · Clinical Psychological Science · doi:10.1177/2167702615577470 · Cited by 38
Associations between oxytocin-related genes and autistic-like traits
Hovey, D., Zettergren, A., Jonsson, L., Melke, J., Anckarsäter, H., Lichtenstein, P., & Westberg, L. (2014) · Social Neuroscience · doi:10.1080/17470919.2014.897995 · Cited by 37
Cirnigliaro, M., Barbagallo, C., Gulisano, M., Domini, C., Barone, R. M. E., Barbagallo, D., Ragusa, M., Pietro, C. D., Rizzo, R., & Purrello, M. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00250 · Cited by 35
Ceroni, F., Sagar, A., Simpson, N. H., Gawthrope, A. J. T., Newbury, D. F., Pinto, D., Francis, S. M., Tessman, D. C., Cook, E. H., Monaco, A. P., et al. (2014) · Autism Research · doi:10.1002/aur.1365 · Cited by 34
Yuhi, T., Kyuta, H., Mori, H.-A., Murakami, C., Furuhara, K., Okuno, M., Takahashi, M., Fuji, D., & Higashida, H. (2017) · Brain Sciences · doi:10.3390/brainsci7110152 · Cited by 32
Self-citationThe Potential of Nasal Oxytocin Administration for Remediation of Autism Spectrum Disorders
Okamoto, Y., Ishitobi, M., Wada, Y., & Kosaka, H. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160413120845 · Cited by 33
Is Oxytocin Application for Autism Spectrum Disorder Evidence-Based?
Lee, S. Y., Lee, A. R., Hwangbo, R., Han, J., Hong, M., & Bahn, G. H. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.312 · Cited by 33
Uruno, A., Noguchi, N., Matsuda, K., Nata, K., Yoshikawa, T., Chikamatsu, Y., Kagechika, H., Harigae, H., Ito, S., Okamoto, H., et al. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0109025 · Cited by 31
Self-citationYuhi, T., Ise, K., Iwashina, K., Terao, N., Yoshioka, S., Shomura, K., Maehara, T., Yazaki, A., Koichi, K., Furuhara, K., et al. (2018) · Behavioral Sciences · doi:10.3390/bs8110101 · Cited by 39
Self-citationAre retinoids potential therapeutic agents in disorders of social cognition including autism?
Ebstein, R. P., Mankuta, D., Yirmiya, N., & Malavasi, F. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.004 · Cited by 32
Self-citationLopatina, O. L., Furuhara, K., Ishihara, K., Salmina, A. B., & Higashida, H. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00266 · Cited by 30
Self-citationA multiscale analysis in CD38 −/− mice unveils major prefrontal cortex dysfunctions
Martucci, L. L., Amar, M., Chaussenot, R., Benet, G., Bauer, O., de Zélicourt, A., Nosjean, A., Launay, J., Callebert, J., Sebrié, C., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201800489r · Cited by 30
The hidden life of NAD+-consuming ectoenzymes in the endocrine system
Malavasi, F., Deaglio, S., Zaccarello, G., Horenstein, A. L., Chillemi, A., Audrito, V., Serra, S., Gandione, M., Zitella, A., & Tizzani, A. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-10-0082 · Cited by 28
Self-citationAssociation Study between the CD157/BST1 Gene and Autism Spectrum Disorders in a Japanese Population
Yokoyama, S., Mahmuda, N. A., Munesue, T., Hayashi, K., Yagi, K., Yamagishi, M., & Higashida, H. (2015) · Brain Sciences · doi:10.3390/brainsci5020188 · Cited by 29
Self-citationHigashida, H., Yuhi, T., Akther, S., Amina, S., Zhong, J., Liang, M., Nishimura, T., Liu, H.-X., & Lopatina, O. L. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.07.009 · Cited by 27
Self-citationIchinose, W., Михайлович, Ч. С., Shabalova, A. A., Yokoyama, S., Yuhi, T., Yamaguchi, H., Watanabe, A., Yamamoto, Y., Okamoto, H., Horike, S., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01691 · Cited by 30
Self-citationCD38–Cyclic ADP-Ribose Signal System in Physiology, Biochemistry, and Pathophysiology
Takasawa, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084306 · Cited by 29
Hirosawa, T., Kikuchi, M., Higashida, H., Okumura, E., Ueno, S., Shitamichi, K., Yoshimura, Y., Munesue, T., Tsubokawa, T., Haruta, Y., et al. (2012) · Scientific Reports · doi:10.1038/srep00384 · Cited by 25
Self-citationFrancis, S. M., Kistner‐Griffin, E., Yan, Z., Guter, S. J., Cook, E. H., & Jacob, S. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00195 · Cited by 28
Negative peer social interactions and oxytocin levels linked to suicidal ideation in anxious youth
Lebowitz, E. R., Blumberg, H. P., & Silverman, W. K. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.070 · Cited by 24
Pairmate-dependent pup retrieval as parental behavior in male mice
Liang, M., Zhong, J., Liu, H.-X., Lopatina, O., Nakada, R., Yamauchi, A.-M., & Higashida, H. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00186 · Cited by 25
Self-citation
Metadata
- Authors
- Munesue, T., Yokoyama, S., Nakamura, K., Anitha, A., Yamada, K., Hayashi, K., Asaka, T., Liu, H.-X., Jin, D., Koizumi, K., Islam, M. S., Huang, J.-J., Ma, W.-J., Kim, U.-H., Kim, S.-J., Park, K., Kim, D., Kikuchi, M., Ono, Y., Nakatani, H., Suda, S., Miyachi, T., Hirai, H., Salmina, A., Pichugina, Y. A., Soumarokov, A. A., Takei, N., Mori, N., Tsujii, M., Sugiyama, T., Yagi, K., Yamagishi, M., Sasaki, T., Yamasue, H., Kato, N., Hashimoto, R., Taniike, M., Hayashi, Y., Hamada, J., Suzuki, S., Ooi, A., Noda, M., Kamiyama, Y., Kido, M. A., Lopatina, O., Hashii, M., Amina, S., Malavasi, F., Huang, E. J., Zhang, J., Shimizu, N., Yoshikawa, T., Matsushima, A., Minabe, Y., & Higashida, H.
- Affiliations
- Kanazawa University (JP)
- Hamamatsu University (JP)
- RIKEN Center for Brain Science (JP)
- Nanao hospital (JP)
- Korea Advanced Institute of Science and Technology (KR)
- Corresponding author
- Higashida, Haruhiro
- ORCID
- Yokoyama, Shigeru
- Nakamura, Kazuhiko
- Anitha, Ayyappan
- Yamada, Kazuo
- Hayashi, Kenshi
- Kim, Uh-Hyun
- Park, Keunwan
- Kim, Dongsup
- Kikuchi, Mitsuru
- Ono, Yasuki
- Suda, Shiro
- Miyachi, Taishi
- Hirai, Hirokazu
- Salmina, Alla
- Tsujii, Masatsugu
- Sugiyama, Toshiro
- Yagi, Kunimasa
- Yamagishi, Masakazu
- Sasaki, Tsukasa
- Yamasue, Hidenori
- Hashimoto, Ryota
- Suzuki, Shioto
- Kido, Mizuho A.
- Lopatina, Olga
- Malavasi, Fabio
- Huang, Eric J.
- Zhang, Jiasheng
- Yoshikawa, Takeo
- Higashida, Haruhiro
- Venue
- Neuroscience Research
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 67
- Issue
- 2
- Pages
- 181-191
- ISSN
- 0168-0102 (ISSN-L)
- OpenAlex
- W2149724047
- Semantic Scholar
- add07ecbc7439e42eee6a7ccfffc8035b6731797
- Cited by
- 177
- References
- 59
- Citations by year
- 2026: 3 · 2024: 5 · 2023: 4 · 2022: 6 · 2021: 7 · 2020: 10 · 2019: 10 · 2018: 13 · 2017: 20 · 2016: 12 · 2015: 20 · 2014: 13 · 2013: 20 · 2012: 14
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- Locations
- Neuroscience Research (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) (submittedVersion, cc-by-nc-nd)
- Funders
- San Francisco State University
- Fondazione Guido Berlucchi
- University of California, San Francisco
- Japan Society for the Promotion of Science (22590202, 21791118, 22590772)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- CD38, autism spectrum disorder, oxytocin, single nucleotide polymorphisms, high-functioning autism, hypothalamus, social recognition, genetic association, plasma oxytocin, family trios, Japanese population
- MeSH terms
- Adolescent, Adult, Aged, Analysis of Variance, Brain, Child, Child Development Disorders, Pervasive, Child, Preschool, Cross-Cultural Comparison, Family Health, Female, Gene Frequency, Genotype, Humans, Immunoenzyme Techniques, Japan, Male, Middle Aged, Oxytocin, Vasopressins, Cohort Studies, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, ADP-ribosyl Cyclase 1, Genome-Wide Association Study, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
